Company profile
OrphAI Therapeutics company profile
AI Therapeutics was founded in 2013 with a mission to advance the clinical development of new therapies to treat Lymphangioleiomyomatosis (LAM) and other diseases. Working with a dedicated team of scientific, clinical, and drug development experts, AI Therapeutics expects to use its disease-specific focus and technological approach to identify and advance drugs that will provide significant therapeutic benefits for LAM patients. AI Therapeutics develops drugs for rare diseases and cancer. LAM takes advantage of the inflection point in biological understanding and computer science, leveraging big data from NextGen sequencing, genome editing, chemical genomics, and combinational drug screening, to develop precision..... For more information, log in to dureach.com to view the full company profile.
Business identity
- Contact email
- [email protected]
- Phone number
- (203)458-7100
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Revenue range
- $1K+
- Founded
- 2013-01-01
Headquarters
- Headquarters
- Rancho Viejo, Texas, United States
- Postal code
- 06437
- Country code
- US
- Continent
- North America